Timber Creek Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$714K Hold
25,433
0.17% 65
2025
Q4
$633K Hold
25,433
0.15% 70
2025
Q3
$648K Hold
25,433
0.16% 75
2025
Q2
$629K Hold
25,433
0.16% 76
2025
Q1
$644K Sell
25,433
-2,756
-10% -$72.1K 0.17% 75
2024
Q4
$748K Sell
28,189
-11
-0% -$298 0.22% 66
2024
Q3
$816K Buy
28,200
+1
+0% +$29 0.23% 70
2024
Q2
$789K Hold
28,199
0.24% 66
2024
Q1
$783K Sell
28,199
-264
-0.9% -$7.33K 0.24% 65
2023
Q4
$819K Sell
28,463
-49,631
-64% -$1.5M 0.28% 55
2023
Q3
$2.59M Sell
78,094
-28,238
-27% -$999K 0.94% 41
2023
Q2
$3.9M Sell
106,332
-284
-0.3% -$11.1K 1.34% 33
2023
Q1
$4.35M Sell
106,616
-1,001
-0.9% -$43.2K 1.55% 28
2022
Q4
$5.51M Sell
107,617
-759
-0.7% -$36.4K 2.09% 15
2022
Q3
$4.74M Buy
108,376
+64
+0.1% +$3.11K 1.88% 21
2022
Q2
$5.68M Sell
108,312
-21,025
-16% -$1.07M 1.88% 19
2022
Q1
$6.7M Sell
129,337
-6,831
-5% -$354K 2.03% 17
2021
Q4
$8.04M Sell
136,168
-13,235
-9% -$656K 2.39% 13
2021
Q3
$6.42M Buy
149,403
+1,385
+0.9% +$61.4K 2.04% 17
2021
Q2
$5.8M Buy
148,018
+35,670
+32% +$1.39M 1.88% 23
2021
Q1
$4.07M Buy
112,348
+6,940
+7% +$246K 1.57% 27
2020
Q4
$3.88M Buy
105,408
+1,791
+2% +$65.7K 1.72% 22
2020
Q3
$3.61M Buy
103,617
+14,962
+17% +$525K 1.98% 19
2020
Q2
$2.75M Buy
88,655
+57,042
+180% +$1.94M 1.72% 26
2020
Q1
$978K Hold
31,613
0.71% 39
2019
Q4
$1.18M Buy
31,613
+317
+1% +$11.3K 0.71% 41
2019
Q3
$1.07M Hold
31,296
0.68% 42
2019
Q2
$1.29M Sell
31,296
-659
-2% -$26.2K 0.83% 39
2019
Q1
$1.29M Sell
31,955
-1,038
-3% -$41.6K 0.87% 37
2018
Q4
$1.37M Sell
32,993
-1,608
-5% -$66.8K 1.06% 34
2018
Q3
$1.45M Sell
34,601
-211
-0.6% -$8.12K 0.93% 35
2018
Q2
$1.2M Sell
34,812
-105
-0.3% -$3.59K 0.78% 41
2018
Q1
$1.18M Sell
34,917
-211
-0.6% -$7.25K 0.74% 40
2017
Q4
$1.21M Hold
35,128
0.75% 40
2017
Q3
$1.19M Sell
35,128
-179
-0.5% -$5.75K 0.8% 40
2017
Q2
$1.13M Sell
35,307
-158
-0.4% -$4.98K 0.77% 41
2017
Q1
$1.15M Buy
35,465
+179
+0.5% +$5.64K 0.86% 36
2016
Q4
$1.09M Sell
35,286
-500
-1% -$15.3K 0.85% 37
2016
Q3
$1.15M Sell
35,786
-19,268
-35% -$644K 0.92% 37
2016
Q2
$1.84M Hold
55,054
1.54% 30
2016
Q1
$1.55M Sell
55,054
-727
-1% -$20.8K 1.39% 34
2015
Q4
$1.71M Sell
55,781
-105
-0.2% -$3.3K 1.53% 31
2015
Q3
$1.67M Sell
55,886
-16,501
-23% -$529K 1.56% 31
2015
Q2
$2.3M Sell
72,387
-58,510
-45% -$1.91M 1.88% 32
2015
Q1
$4.32M Buy
130,897
+104
+0.1% +$3.31K 3.44% 7
2014
Q4
$3.87M Sell
130,793
-15,380
-11% -$441K 3.01% 9
2014
Q3
$4.1M Buy
146,173
+343
+0.2% +$9.63K 3.43% 11
2014
Q2
$4.11M Buy
145,830
+3,620
+3% +$103K 3.42% 12
2014
Q1
$4.33M Buy
142,210
+1,950
+1% +$58.1K 3.94% 9
2013
Q4
$4.08M Sell
140,260
-13,315
-9% -$388K 3.8% 10
2013
Q3
$4.18M Buy
153,575
+1,623
+1% +$44.2K 3.83% 8
2013
Q2
$4.04M Buy
+151,952
New +$4.2M 3.74% 9

Other funds holding PFE

Timber Creek Capital Management's PFE Position: Q1 2026 in Review

Timber Creek Capital Management held its Pfizer (PFE) position steady in Q1 2026 at 25,433 shares worth $714K. The position accounts for 0.17% of the portfolio, ranked #65.

Timber Creek Capital Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.04M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Timber Creek Capital Management held 25,433 shares of Pfizer worth $714K as of Q1 2026.
  • Timber Creek Capital Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.17% of Timber Creek Capital Management's portfolio in Q1 2026, its #65 holding.
  • Timber Creek Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Timber Creek Capital Management's Pfizer position peaked at $8.04M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Timber Creek Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.